Susquehanna Reiterates Neutral Rating for Humana Inc. (HUM)
Humana Inc. (NYSE:HUM)‘s stock had its “neutral” rating reaffirmed by research analysts at Susquehanna in a research report issued on Thursday. They currently have a $180.00 price objective on the insurance provider’s stock. Susquehanna’s price objective would indicate a potential upside of 5.37% from the stock’s current price.
Several other research firms also recently weighed in on HUM. Jefferies Group upgraded shares of Humana from a “hold” rating to a “buy” rating and lifted their target price for the stock from $158.89 to $210.00 in a research note on Monday, July 18th. JPMorgan Chase & Co. downgraded shares of Humana from an “overweight” rating to a “neutral” rating and reduced their target price for the stock from $196.00 to $150.00 in a research note on Friday, July 8th. Argus reiterated a “hold” rating on shares of Humana in a research note on Tuesday, August 23rd. Wolfe Research initiated coverage on shares of Humana in a research note on Tuesday, June 28th. They issued a “market perform” rating and a $244.00 target price for the company. Finally, Credit Suisse Group AG lifted their target price on shares of Humana from $175.00 to $188.00 and gave the stock a “neutral” rating in a research note on Tuesday, August 16th. Seven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. The stock currently has a consensus rating of “Buy” and a consensus target price of $200.50.
Humana (NYSE:HUM) opened at 170.82 on Thursday. The company has a 50-day moving average of $175.94 and a 200 day moving average of $175.74. Humana has a 52 week low of $150.00 and a 52 week high of $191.65. The company has a market cap of $25.46 billion, a P/E ratio of 26.24 and a beta of 0.90.
Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, August 3rd. The insurance provider reported $2.30 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.23 by $0.07. Humana had a net margin of 1.76% and a return on equity of 11.11%. The business earned $14 billion during the quarter, compared to the consensus estimate of $13.59 billion. During the same quarter last year, the company posted $1.67 earnings per share. The firm’s quarterly revenue was up 2.0% compared to the same quarter last year. On average, equities analysts forecast that Humana will post $9.24 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Thursday, October 13th will be issued a $0.29 dividend. The ex-dividend date is Tuesday, October 11th. This represents a $1.16 dividend on an annualized basis and a dividend yield of 0.68%. Humana’s payout ratio is 18.18%.
Several large investors have recently made changes to their positions in the company. Vanguard Group Inc. raised its stake in shares of Humana by 2.5% in the second quarter. Vanguard Group Inc. now owns 8,964,492 shares of the insurance provider’s stock worth $1,612,532,000 after buying an additional 219,311 shares during the last quarter. BlackRock Institutional Trust Company N.A. raised its stake in shares of Humana by 3.2% in the second quarter. BlackRock Institutional Trust Company N.A. now owns 3,908,027 shares of the insurance provider’s stock worth $702,976,000 after buying an additional 120,720 shares during the last quarter. Arrowgrass Capital Partners US LP raised its stake in shares of Humana by 1.8% in the first quarter. Arrowgrass Capital Partners US LP now owns 2,878,848 shares of the insurance provider’s stock worth $526,685,000 after buying an additional 51,267 shares during the last quarter. Evercore Trust Company N.A. raised its stake in shares of Humana by 3.0% in the second quarter. Evercore Trust Company N.A. now owns 2,570,366 shares of the insurance provider’s stock worth $462,357,000 after buying an additional 75,126 shares during the last quarter. Finally, BlackRock Fund Advisors raised its stake in shares of Humana by 2.5% in the second quarter. BlackRock Fund Advisors now owns 2,074,281 shares of the insurance provider’s stock worth $373,122,000 after buying an additional 51,378 shares during the last quarter. Hedge funds and other institutional investors own 93.24% of the company’s stock.
Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.
Receive News & Ratings for Humana Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana Inc. and related companies with MarketBeat.com's FREE daily email newsletter.